|
| Exchange Disseminated Time | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, has considered & approved the following:
1. a. Mr. S.N. Kamath’s tenure as Managing Director is extended by 3 years starting from April 01, 2016 and annual salary of Rs. 1.5cr- 1.75cr - 2cr.
b. Dr. Vibha Gagan Sharma’s tenure as Wholetime Director is extended by 3 years starting from January 27, 2016 and annual salary of Rs. 35 lakh - 40 lakh - 45 lakh.
c. Mrs. Shruti Vishal Rao’s tenure as Wholetime Director is extended by 3 years starting from April 01, 2016 and annual salary of Rs. 35 lakh-40 lakh -45 lakh.
2. Mr. S. N. Kamath has been authorized to sign and execute the New Listing Agreement as per the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) with Stock Exchanges.
3. Pursuant to Regulation 30 (5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. |
|
|